CIK 0001498382 · Non-accelerated filer<br>Smaller reporting company
TuHURA Biosciences, Inc./NV
Sign in to watch- Ticker
- HURA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 990360497
- Phone
- 813-875-6600
- Business address
- 10500 UNIVERSITY CENTER DR., SUITE 110, TAMPA, FL, 33612
- Former names
- Kintara Therapeutics, Inc., DelMar Pharmaceuticals, Inc., Berry Only Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-09-30 | Bell John K Director | Other acquisition | +29 | 9,730 | ||
| 2019-09-30 | Praill Anthony Scott Chief Financial Officer | Other acquisition | +22 | 7,408 | ||
| 2019-09-30 | Brown Dennis M Chief Scientific Officer | Other acquisition | +17 | 13,460 | ||
| 2019-09-13 | Bell John K Director | Purchase | +35,000 | $0.68 | $24K | 35,000 |
| 2019-09-13 | Bell John K Director | Purchase | +35,000 | $0.68 | $24K | 44,701 |
| 2019-09-05 | Ferrara Napoleone Director | Grant or award · Options (Right to Buy) | +39,567 | 39,567 | ||
| 2019-09-05 | Ferrara Napoleone Director | Grant or award · Options (Right to Buy) | +35,433 | 35,433 | ||
| 2019-09-05 | Bell John K Director | Grant or award · Options (Right to Buy) | +39,567 | 39,567 | ||
| 2019-09-05 | Bell John K Director | Grant or award · Options (Right to Buy) | +35,433 | 35,433 | ||
| 2019-09-05 | HOFFMAN ROBERT Director | Grant or award · Options (Right to Buy) | +39,567 | 39,567 | ||
| 2019-09-05 | HOFFMAN ROBERT Director | Grant or award · Options (Right to Buy) | +35,433 | 35,433 | ||
| 2019-09-05 | Brown Dennis M Chief Scientific Officer | Grant or award · Options (Right to Buy) | +52,756 | 52,756 | ||
| 2019-09-05 | Brown Dennis M Chief Scientific Officer | Grant or award · Options (Right to Buy) | +47,244 | 47,244 | ||
| 2019-09-05 | Zarrabian Saiid President and CEO | Grant or award · Options (Right to Buy) | +241,438 | 241,438 | ||
| 2019-09-05 | Zarrabian Saiid President and CEO | Grant or award · Options (Right to Buy) | +216,212 | 216,212 | ||
| 2019-09-05 | Cranston Lynda Sarah Director | Grant or award · Options (Right to Buy) | +39,567 | 39,567 | ||
| 2019-09-05 | Cranston Lynda Sarah Director | Grant or award · Options (Right to Buy) | +35,433 | 35,433 | ||
| 2019-09-05 | Praill Anthony Scott Chief Financial Officer | Grant or award · Options (Right to Buy) | +57,170 | 57,170 | ||
| 2019-09-05 | Praill Anthony Scott Chief Financial Officer | Grant or award · Options (Right to Buy) | +51,196 | 51,196 | ||
| 2019-09-05 | TOTH ROBERT JOSEPH JR Director | Grant or award · Options (Right to Buy) | +39,567 | 39,567 |
Page 7 of 18 · 357 trades